Resource use in decompensated heart failure by disease progression categories.

The purpose of this study was to quantify the total hospital resource use for decompensated heart failure according to disease progression categories. Clinical and cost information was obtained from an electronic data repository and chart review. During the 1-year period from June 2002 to June 2003, qualified patients were categorized based on disease progression as (1) new onset, (2) known heart failure, or (3) readmission. The primary outcome variables were total hospital resource use and resource use by services. Analysis of variance, Scheffé analysis for pairwise comparisons, and chi-square analysis were performed to determine differences among groups. Total hospitalization costs are similar whether it is a new diagnosis of heart failure, known diagnosis, or readmission. Among the 3 categories, 5 services contained statistically significant differences in costs (P<.05): echocardiography, electrophysiology, neurodiagnostic, nuclear cardiology, and pharmacy. Careful analysis of hospital resource use by services for heart failure patients provides opportunities for institutional cost containment.

[1]  Amy L. Seybert,et al.  Outcomes and Costs of Abciximab Versus Eptifibatide for Percutaneous Coronary Intervention , 2005, The Annals of pharmacotherapy.

[2]  J. McMurray,et al.  Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.

[3]  I. Gradus-Pizlo,et al.  Health care and medication costs and use among older adults with heart failure. , 2004, The American journal of medicine.

[4]  Haya R Rubin,et al.  Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. , 2004, JAMA.

[5]  A. Joshi,et al.  Differences in hospital length-of-stay, charges, and mortality in congestive heart failure patients. , 2004, Congestive heart failure.

[6]  Pamela S Douglas,et al.  Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .

[7]  Robert J Weber,et al.  Impact of intensive care unit (ICU) drug use on hospital costs: A descriptive analysis, with recommendations for optimizing ICU pharmacotherapy , 2003, Critical care medicine.

[8]  H. Krumholz,et al.  Predictors of costs of caring for elderly patients discharged with heart failure. , 2001, American heart journal.

[9]  G. Fonarow.  The treatment targets in acute decompensated heart failure. , 2001, Reviews in cardiovascular medicine.

[10]  M. Nichaman,et al.  Congestive heart failure in the United States: is there more than meets the I(CD code)? The Corpus Christi Heart Project. , 2000, Archives of internal medicine.

[11]  J. Hausleiter,et al.  Leakage of a liquid 188Re-filled balloon system during intracoronary brachytherapy. A case report. , 2000, Cardiovascular radiation medicine.

[12]  D. Gregori,et al.  Use of medical resources and quality of life of patients with chronic heart failure: a prospective survey in a large Italian community hospital , 1999, European journal of heart failure.

[13]  B. Massie,et al.  Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. , 1997, American heart journal.

[14]  Y Wang,et al.  Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. , 1997, Archives of internal medicine.